Skip to main content
. 2021 Feb;22(2):509–516. doi: 10.31557/APJCP.2021.22.2.509

Table 3.

Frequency of Serum Antibodies against Salmonella Typhi (Vi and O) and Salmonella Paratyphi (AO and BO) in Cases and Controls

GBC XGC CC HC Comparisons among different groups OR 95% CI *P-value among different subgroups Overall *P-value
No. Positive
No. (%)
No. Positive
No. (%)
No. Positive
No. (%)
No. Positive
No. (%)
Salmonella typhi Vi antibody
Male 26 6 (23)a 13 0 75 14 (19) 191 3 (2) GBC vs. HC
GBC vs. CC
GBC vs. XGC
XGC vs. HC
XGC vs. CC
18.8
1.3
8.6
1.9
0.16
4.4-81.0
0.4-3.8
0.4-165
0.0-40.7
0.0-2.8
< 0.001
0.63
0.06
0.65
0.09
< 0.001
Female 74 7 (9) 11 2 (18) 124 16 (13) 9 0 GBC vs. HC
GBC vs. CC
GBC vs. XGC
XGC vs. HC
XGC vs. CC
2.1
0.7
0.5
5.0
1.5
0.1-40.1
0.3-1.8
0.1-2.6
0.2-118.7
0.3-7.6
0.33
0.48
0.38
0.18
0.61
0.54
Total 100 13 (13)a 24 2 (8)b 200 30 (15) 200 3 (2) GBC vs. HC
GBC vs. CC
GBC vs. XGC
XGC vs. HC
XGC vs. CC
9.8
0.8
1.6
5.9
0.5
2.7-35.3
0.4-1.7
0.3-7.8
0.9-37.7
0.1-2.3
< 0.001
0.64
0.53
0.03
0.38
< 0.001
Salmonella typhi O antibody
Male 26 3 (12)a,c 13 1 (8) 75 1 (1) 191 2 (1) GBC vs. HC
GBC vs. CC
GBC vs. XGC
XGC vs. HC
XGC vs. CC
12.3
9.7
1.6
7.9
6.2
1.9-77.7
0.9-97.4
0.1-16.7
0.7-93.1
0.4-105
0.001
0.02
0.71
0.054
0.15
0.004
Female 74 5 (7) 11 1 (9) 125 6 (5) 9 0 GBC vs. HC
GBC vs. CC
GBC vs. XGC
XGC vs. HC
XGC vs. CC
1.5
1.4
0.7
2.7
1.9
0.1-29.4
0.4-4.9
0.1-6.9
0.1-75.1
0.2-18.2
0.42
0.56
0.78
0.35
0.54
0.75
Total 100 8 (8)a 24 2 (8)b 200 7 (3) 200 2 (1) GBC vs. HC
GBC vs. CC
GBC vs. XGC
XGC vs. HC
XGC vs. CC
8.6
2.3
0.9
9.0
2.5
1.7-41.3
0.8-6.8
0.2-4.8
1.2-67.1
0.4-12.8
0.001
0.09
0.96
0.01
0.25
0.012
O antibody for Salmonella paratyphi A
Male 26 2 (8)a 13 2 (15) b 75 10 (13) 191 0 GBC vs. HC
GBC vs. CC
GBC vs. XGC
XGC vs. HC
XGC vs. CC
39.1
0.5
0.5
83.3
1.2
1.8-838
0.1-2.7
0.1-3.7
3.8-1839
0.2-6.1
0.001
0.44
0.45
<0.001
0.84
< 0.001
GBC XGC CC HC Comparisons among different groups OR 95% CI *P-value among different subgroups Overall *P-value
No. Positive No. (%) No. Positive No. (%) No. Positive No. (%) No. Positive No. (%)
O antibody for Salmonella paratyphi A
Female 74 4 (5) 11 0 125 10 (8) 9 0 GBC vs. HC
GBC vs. CC
GBC vs. XGC
XGC vs. HC
XGC vs. CC
1.2
0.7
1.5
NA
0.48
0.1-24.4
0.2-2.2
0.0-29.1
NA
0.0-8.7
0.47
0.49
0.43
NA
0.33
0.57
Total 100 6 (6)a 24 2 (8)b 200 20 (10) 200 0 GBC vs. HC
GBC vs. CC
GBC vs. XGC
XGC vs. HC
XGC vs. CC
27.5
0.5
0.7
44.5
0.8
1.5-495
0.2-1.4
0.1-3.7
2.0-958
0.2-3.7
0.001
0.24
0.68
<0.001
0.79
0.001
O antibody for Salmonella paratyphi B
Male 26 3 (8)a 13 2 (15) b 75 5 (7) 191 0 GBC vs. HC
GBC vs. CC
GBC vs. XGC
XGC vs. HC
XGC vs. CC
57
1.8
0.7
83.2
2.5
2.9-1140
0.4-8.2
0.1-4.9
3.7-1839
0.4-14.8
<0.001
0.43
0.73
<0.001
0.28
0.001
Female 74 1 (1) 11 1 (9) 125 6 (5) 9 0 GBC vs. HC
GBC vs. CC
GBC vs. XGC
XGC vs. HC
XGC vs. CC
0.4
0.3
0.1
2.7
1.9
0.0-10.2
0.0-2.3
0.0-2.4
0.0-75.1
0.2-18.2
0.73
0.2
0.11
0.35
0.54
0.42
Total 100 4 (4)a 24 3 (12)b 200 11(5) 200 0 GBC vs. HC
GBC vs. CC
GBC vs. XGC
XGC vs. HC
XGC vs. CC
18.7
0.7
0.2
65.2
2.4
0.9-351
0.2-2.3
0.0-1.4
3.2-1307
0.6-9.5
0.004
0.57
0.1
<0.001
0.18
0.001

CC, Chronic cholecystitis ; GBC, Gall bladder cancer; HC, Healthy controls ; XGC, Xanthogranulomatous cholecystitis;*Chi-square test was used; OR, Odds ratio; NA, Not applicable as there is no positive case in XGC vs. HC; aP <0.01 between GBC vs. HC; bP <0.05 between XGC vs. HC; cP <0.05 between GBC vs. CC